{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:09:14Z","timestamp":1792807754657,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["01EO1302"],"award-info":[{"award-number":["01EO1302"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["422182557"],"award-info":[{"award-number":["422182557"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Tracer kinetic modeling of tissue time activity curves and the individual input function based on arterial blood sampling and metabolite correction is the gold standard for quantitative characterization of microglia activation by PET with the translocator protein (TSPO) ligand <jats:sup>18<\/jats:sup>F-GE-180. This study tested simplified methods for quantification of <jats:sup>18<\/jats:sup>F-GE-180 PET.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Dynamic <jats:sup>18<\/jats:sup>F-GE-180 PET with arterial blood sampling and metabolite correction was performed in five healthy volunteers and 20 liver-transplanted patients. Population-based input function templates were generated by averaging individual input functions normalized to the total area under the input function using a leave-one-out approach. Individual population-based input functions were obtained by scaling the input function template with the individual parent activity concentration of <jats:sup>18<\/jats:sup>F-GE-180 in arterial plasma in a blood sample drawn at 27.5\u00a0min or by the individual administered tracer activity, respectively. The total <jats:sup>18<\/jats:sup>F-GE-180 distribution volume (V<jats:sub>T<\/jats:sub>) was estimated in 12 regions-of-interest (ROIs) by the invasive Logan plot using the measured or the population-based input functions. Late ROI-to-whole-blood and ROI-to-cerebellum ratio were also computed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Correlation with the reference V<jats:sub>T<\/jats:sub> (with individually measured input function) was very high for V<jats:sub>T<\/jats:sub> with the population-based input function scaled with the blood sample and for the ROI-to-whole-blood ratio (Pearson correlation coefficient\u2009=\u20090.989\u2009\u00b1\u20090.006 and 0.970\u2009\u00b1\u20090.005). The correlation was only moderate for V<jats:sub>T<\/jats:sub> with the population-based input function scaled with tracer activity dose and for the ROI-to-cerebellum ratio (0.653\u2009\u00b1\u20090.074 and 0.384\u2009\u00b1\u20090.177). Reference V<jats:sub>T<\/jats:sub>, population-based V<jats:sub>T<\/jats:sub> with scaling by the blood sample, and ROI-to-whole-blood ratio were sensitive to the TSPO gene polymorphism. Population-based V<jats:sub>T<\/jats:sub> with scaling to the administered tracer activity and the ROI-to-cerebellum ratio failed to detect a polymorphism effect.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results support the use of a population-based input function scaled with a single blood sample or the ROI-to-whole-blood ratio at a late time point for simplified quantitative analysis of <jats:sup>18<\/jats:sup>F-GE-180 PET.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00259-020-04810-1","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:02:28Z","timestamp":1587600148000},"page":"2887-2900","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Reliable quantification of 18F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0945-0724","authenticated-orcid":false,"given":"Ralph","family":"Buchert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Dirks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sch\u00fctze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mamach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Katrin","family":"Wirries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Pflugrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hamann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B.N.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wetzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Lukacevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Polyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Petrusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Bengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilli","family":"Geworski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Weissenborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias L.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Berding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"key":"4810_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14:463\u201377. https:\/\/doi.org\/10.1038\/nri3705.","journal-title":"Nat Rev Immunol"},{"key":"4810_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nrd3295","volume":"9","author":"R Rupprecht","year":"2010","unstructured":"Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov. 2010;9:971\u201388. https:\/\/doi.org\/10.1038\/nrd3295.","journal-title":"Nat Rev Drug Discov"},{"key":"4810_CR3","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.bbi.2009.09.010","volume":"24","author":"A Denes","year":"2010","unstructured":"Denes A, Thornton P, Rothwell NJ, Allan SM. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun. 2010;24:708\u201323. https:\/\/doi.org\/10.1016\/j.bbi.2009.09.010.","journal-title":"Brain Behav Immun"},{"issue":"Pt 11","key":"4810_CR4","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1093\/brain\/123.11.2321","volume":"123","author":"RB Banati","year":"2000","unstructured":"Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 2000;123(Pt 11):2321\u201337. https:\/\/doi.org\/10.1093\/brain\/123.11.2321.","journal-title":"Brain."},{"key":"4810_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-006-9199-9","volume":"81","author":"E Vlodavsky","year":"2007","unstructured":"Vlodavsky E, Soustiel JF. Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival. J Neuro-Oncol. 2007;81:1\u20137. https:\/\/doi.org\/10.1007\/s11060-006-9199-9.","journal-title":"J Neuro-Oncol"},{"key":"4810_CR6","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.jceh.2014.07.006","volume":"5","author":"AR Jayakumar","year":"2015","unstructured":"Jayakumar AR, Rama Rao KV, Norenberg MD. Neuroinflammation in hepatic encephalopathy: mechanistic aspects. J Clin Exp Hepatol. 2015;5:S21\u20138. https:\/\/doi.org\/10.1016\/j.jceh.2014.07.006.","journal-title":"J Clin Exp Hepatol"},{"key":"4810_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","volume":"72","author":"E Setiawan","year":"2015","unstructured":"Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry. 2015;72:268\u201375. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.2427.","journal-title":"JAMA Psychiatry"},{"key":"4810_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0006-8993(87)91287-x","volume":"421","author":"J Benavides","year":"1987","unstructured":"Benavides J, Fage D, Carter C, Scatton B. Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res. 1987;421:167\u201372. https:\/\/doi.org\/10.1016\/0006-8993(87)91287-x.","journal-title":"Brain Res"},{"key":"4810_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2007.12.004","volume":"118","author":"MK Chen","year":"2008","unstructured":"Chen MK, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008;118:1\u201317. https:\/\/doi.org\/10.1016\/j.pharmthera.2007.12.004.","journal-title":"Pharmacol Ther"},{"key":"4810_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1042\/Bj20150899","volume":"473","author":"J Gatliff","year":"2016","unstructured":"Gatliff J, Campanella M. TSPO: kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria. Biochem J. 2016;473:107\u201321. https:\/\/doi.org\/10.1042\/Bj20150899.","journal-title":"Biochem J"},{"key":"4810_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.pneurobio.2006.10.002","volume":"80","author":"S Venneti","year":"2006","unstructured":"Venneti S, Lopresti BJ, Wiley CA. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol. 2006;80:308\u201322. https:\/\/doi.org\/10.1016\/j.pneurobio.2006.10.002.","journal-title":"Prog Neurobiol"},{"key":"4810_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13244-011-0128-x","volume":"3","author":"AS Ching","year":"2012","unstructured":"Ching AS, Kuhnast B, Damont A, Roeda D, Tavitian B, Dolle F. Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases. Insights Imag. 2012;3:111\u20139. https:\/\/doi.org\/10.1007\/s13244-011-0128-x.","journal-title":"Insights Imag"},{"key":"4810_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/glia.10144","volume":"40","author":"RB Banati","year":"2002","unstructured":"Banati RB. Visualising microglial activation in vivo. Glia. 2002;40:206\u201317. https:\/\/doi.org\/10.1002\/glia.10144.","journal-title":"Glia."},{"key":"4810_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","volume":"358","author":"A Cagnin","year":"2001","unstructured":"Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358:461\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(01)05625-2.","journal-title":"Lancet."},{"key":"4810_CR15","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1007\/s00259-008-0908-9","volume":"35","author":"F Chauveau","year":"2008","unstructured":"Chauveau F, Boutin H, Van Camp N, Dolle F, Tavitian B. Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging. 2008;35:2304\u201319. https:\/\/doi.org\/10.1007\/s00259-008-0908-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4810_CR16","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.bmcl.2011.12.084","volume":"22","author":"H Wadsworth","year":"2012","unstructured":"Wadsworth H, Jones PA, Chau WF, Durrant C, Fouladi N, Passmore J, et al. [(1)(8)F]GE-180: a novel fluorine-18 labelled PET tracer for imaging translocator protein 18 kDa (TSPO). Bioorg Med Chem Lett. 2012;22:1308\u201313. https:\/\/doi.org\/10.1016\/j.bmcl.2011.12.084.","journal-title":"Bioorg Med Chem Lett"},{"key":"4810_CR17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2967\/jnumed.113.125625","volume":"55","author":"AM Dickens","year":"2014","unstructured":"Dickens AM, Vainio S, Marjamaki P, Johansson J, Lehtiniemi P, Rokka J, et al. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180. J Nucl Med. 2014;55:466\u201372. https:\/\/doi.org\/10.2967\/jnumed.113.125625.","journal-title":"J Nucl Med"},{"key":"4810_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00259-014-2939-8","volume":"42","author":"H Boutin","year":"2015","unstructured":"Boutin H, Murray K, Pradillo J, Maroy R, Smigova A, Gerhard A, et al. 18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke. Eur J Nucl Med Mol Imaging. 2015;42:503\u201311. https:\/\/doi.org\/10.1007\/s00259-014-2939-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4810_CR19","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.7150\/thno.17666","volume":"7","author":"ML James","year":"2017","unstructured":"James ML, Belichenko NP, Shuhendler AJ, Hoehne A, Andrews LE, Condon C, et al. [(18)F]GE-180 PET detects reduced microglia activation after LM11A-31 therapy in a mouse model of Alzheimer\u2019s disease. Theranostics. 2017;7:1422\u201336. https:\/\/doi.org\/10.7150\/thno.17666.","journal-title":"Theranostics."},{"key":"4810_CR20","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2967\/jnumed.115.169078","volume":"57","author":"Z Fan","year":"2016","unstructured":"Fan Z, Calsolaro V, Atkinson RA, Femminella GD, Waldman A, Buckley C, et al. Flutriciclamide (F-18-GE180) PET: first-in-human PET study of novel third-generation in vivo marker of human translocator protein. J Nucl Med. 2016;57:1753\u20139. https:\/\/doi.org\/10.2967\/jnumed.115.169078.","journal-title":"J Nucl Med"},{"key":"4810_CR21","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s00259-016-3444-z","volume":"43","author":"C Feeney","year":"2016","unstructured":"Feeney C, Scott G, Raffel J, Roberts S, Coello C, Jolly A, et al. Kinetic analysis of the translocator protein positron emission tomography ligand [F-18]GE-180 in the human brain. Eur J Nucl Med Mol I. 2016;43:2201\u201310. https:\/\/doi.org\/10.1007\/s00259-016-3444-z.","journal-title":"Eur J Nucl Med Mol I"},{"key":"4810_CR22","first-page":"158","volume":"48","author":"FE Turkheimer","year":"2007","unstructured":"Turkheimer FE, Edison P, Pavese N, Roncaroli F, Anderson AN, Hammers A, et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J Nucl Med. 2007;48:158\u201367.","journal-title":"J Nucl Med"},{"key":"4810_CR23","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/jcbfm.2012.59","volume":"32","author":"M Yaqub","year":"2012","unstructured":"Yaqub M, van Berckel BN, Schuitemaker A, Hinz R, Turkheimer FE, Tomasi G, et al. Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies. J Cereb Blood Flow Metab. 2012;32:1600\u20138. https:\/\/doi.org\/10.1038\/jcbfm.2012.59.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4810_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13550-017-0340-x","volume":"7","author":"L Vomacka","year":"2017","unstructured":"Vomacka L, Albert NL, Lindner S, Unterrainer M, Mahler C, Brendel M, et al. TSPO imaging using the novel PET ligand [(18)F]GE-180: quantification approaches in patients with multiple sclerosis. EJNMMI Res. 2017;7:89. https:\/\/doi.org\/10.1186\/s13550-017-0340-x.","journal-title":"EJNMMI Res"},{"key":"4810_CR25","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1007\/s00259-017-3799-9","volume":"44","author":"NL Albert","year":"2017","unstructured":"Albert NL, Unterrainer M, Fleischmann DF, Lindner S, Vettermann F, Brunegraf A, et al. TSPO PET for glioma imaging using the novel ligand (18)F-GE-180: first results in patients with glioblastoma. Eur J Nucl Med Mol Imaging. 2017;44:2230\u20138. https:\/\/doi.org\/10.1007\/s00259-017-3799-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4810_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1148\/radiology.188.1.8511286","volume":"188","author":"S Takikawa","year":"1993","unstructured":"Takikawa S, Dhawan V, Spetsieris P, Robeson W, Chaly T, Dahl R, et al. Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology. 1993;188:131\u20136. https:\/\/doi.org\/10.1148\/radiology.188.1.8511286.","journal-title":"Radiology."},{"key":"4810_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.compmedimag.2006.07.002","volume":"30","author":"M Bentourkia","year":"2006","unstructured":"Bentourkia M. Kinetic modeling of PET-FDG in the brain without blood sampling. Comput Med Imaging Graph. 2006;30:447\u201351. https:\/\/doi.org\/10.1016\/j.compmedimag.2006.07.002.","journal-title":"Comput Med Imaging Graph"},{"key":"4810_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/bf02984467","volume":"18","author":"S Takagi","year":"2004","unstructured":"Takagi S, Takahashi W, Shinohara Y, Yasuda S, Ide M, Shohtsu A, et al. Quantitative PET cerebral glucose metabolism estimates using a single non-arterialized venous-blood sample. Ann Nucl Med. 2004;18:297\u2013302. https:\/\/doi.org\/10.1007\/bf02984467.","journal-title":"Ann Nucl Med"},{"key":"4810_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/bf01728767","volume":"24","author":"S Eberl","year":"1997","unstructured":"Eberl S, Anayat AR, Fulton RR, Hooper PK, Fulham MJ. Evaluation of two population-based input functions for quantitative neurological FDG PET studies. Eur J Nucl Med. 1997;24:299\u2013304. https:\/\/doi.org\/10.1007\/bf01728767.","journal-title":"Eur J Nucl Med"},{"key":"4810_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2191-219X-2-11","volume":"2","author":"KB Contractor","year":"2012","unstructured":"Contractor KB, Kenny LM, Coombes CR, Turkheimer FE, Aboagye EO, Rosso L. Evaluation of limited blood sampling population input approaches for kinetic quantification of [18F]fluorothymidine PET data. EJNMMI Res. 2012;2:11. https:\/\/doi.org\/10.1186\/2191-219X-2-11.","journal-title":"EJNMMI Res"},{"key":"4810_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/jcbfm.2014.194","volume":"35","author":"E Rissanen","year":"2015","unstructured":"Rissanen E, Tuisku J, Luoto P, Arponen E, Johansson J, Oikonen V, et al. Automated reference region extraction and population-based input function for brain [(11)C]TMSX PET image analyses. J Cereb Blood Flow Metab. 2015;35:157\u201365. https:\/\/doi.org\/10.1038\/jcbfm.2014.194.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4810_CR32","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.neuroimage.2012.08.007","volume":"63","author":"P Zanotti-Fregonara","year":"2012","unstructured":"Zanotti-Fregonara P, Hines CS, Zoghbi SS, Liow JS, Zhang Y, Pike VW, et al. Population-based input function and image-derived input function for [(1)(1)C](R)-rolipram PET imaging: methodology, validation and application to the study of major depressive disorder. Neuroimage. 2012;63:1532\u201341. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.08.007.","journal-title":"Neuroimage."},{"key":"4810_CR33","doi-asserted-by":"publisher","first-page":"e60231","DOI":"10.1371\/journal.pone.0060231","volume":"8","author":"P Zanotti-Fregonara","year":"2013","unstructured":"Zanotti-Fregonara P, Hirvonen J, Lyoo CH, Zoghbi SS, Rallis-Frutos D, Huestis MA, et al. Population-based input function modeling for [(18)F]FMPEP-d 2, an inverse agonist radioligand for cannabinoid CB1 receptors: validation in clinical studies. PLoS One. 2013;8:e60231. https:\/\/doi.org\/10.1371\/journal.pone.0060231.","journal-title":"PLoS One"},{"key":"4810_CR34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00259-011-2004-9","volume":"39","author":"P Zanotti-Fregonara","year":"2012","unstructured":"Zanotti-Fregonara P, Maroy R, Peyronneau MA, Trebossen R, Bottlaender M. Minimally invasive input function for 2-18F-fluoro-A-85380 brain PET studies. Eur J Nucl Med Mol Imaging. 2012;39:651\u20139. https:\/\/doi.org\/10.1007\/s00259-011-2004-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4810_CR35","first-page":"955","volume":"35","author":"S Takikawa","year":"1994","unstructured":"Takikawa S, Dhawan V, Chaly T, Robeson W, Dahl R, Zanzi I, et al. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations. J Nucl Med. 1994;35:955\u201363.","journal-title":"J Nucl Med"},{"key":"4810_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13550-016-0208-5","volume":"6","author":"F Hofheinz","year":"2016","unstructured":"Hofheinz F, Hoff J, Steffen IG, Lougovski A, Ego K, Amthauer H, et al. Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET. EJNMMI Res. 2016;6:53. https:\/\/doi.org\/10.1186\/s13550-016-0208-5.","journal-title":"EJNMMI Res"},{"key":"4810_CR37","doi-asserted-by":"publisher","unstructured":"Braune A, Hofheinz F, Bluth T, Kiss T, Wittenstein J, Scharffenberg M, et al. Comparison of static (18)F-FDG-PET\/CT (SUV, SUR) and dynamic (18)F-FDG-PET\/CT (Ki) for quantification of pulmonary inflammation in acute lung injury. J Nucl Med. 2019. https:\/\/doi.org\/10.2967\/jnumed.119.226597.","DOI":"10.2967\/jnumed.119.226597"},{"key":"4810_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","volume":"32","author":"DR Owen","year":"2012","unstructured":"Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 2012;32:1\u20135. https:\/\/doi.org\/10.1038\/jcbfm.2011.147.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4810_CR39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/jlcr.3112","volume":"57","author":"T Wickstrom","year":"2014","unstructured":"Wickstrom T, Clarke A, Gausemel I, Horn E, Jorgensen K, Khan I, et al. The development of an automated and GMP compliant FASTlab synthesis of [(18) F]GE-180; a radiotracer for imaging translocator protein (TSPO). J Labelled Comp Radiopharm. 2014;57:42\u20138. https:\/\/doi.org\/10.1002\/jlcr.3112.","journal-title":"J Labelled Comp Radiopharm"},{"key":"4810_CR40","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.nucmedbio.2015.05.004","volume":"42","author":"WF Chau","year":"2015","unstructured":"Chau WF, Black AM, Clarke A, Durrant C, Gausemel I, Khan I, et al. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180. Nucl Med Biol. 2015;42:711\u20139. https:\/\/doi.org\/10.1016\/j.nucmedbio.2015.05.004.","journal-title":"Nucl Med Biol"},{"key":"4810_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s002590000405","volume":"28","author":"R Boellaard","year":"2001","unstructured":"Boellaard R, van Lingen A, van Balen SCM, Hoving BG, Lammertsma AA. Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET. Eur J Nucl Med. 2001;28:81\u20139. https:\/\/doi.org\/10.1007\/s002590000405.","journal-title":"Eur J Nucl Med"},{"key":"4810_CR42","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neuroimage.2012.03.020","volume":"61","author":"C Rorden","year":"2012","unstructured":"Rorden C, Bonilha L, Fridriksson J, Bender B, Karnath HO. Age-specific CT and MRI templates for spatial normalization. Neuroimage. 2012;61:957\u201365. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.03.020.","journal-title":"Neuroimage."},{"key":"4810_CR43","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","volume":"10","author":"J Logan","year":"1990","unstructured":"Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740\u20137. https:\/\/doi.org\/10.1038\/jcbfm.1990.127.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4810_CR44","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.2967\/jnumed.117.203109","volume":"59","author":"P Zanotti-Fregonara","year":"2018","unstructured":"Zanotti-Fregonara P, Pascual B, Rizzo G, Yu M, Pal N, Beers D, et al. Head-to-head comparison of (11)C-PBR28 and (18)F-GE180 for quantification of the translocator protein in the human brain. J Nucl Med. 2018;59:1260\u20136. https:\/\/doi.org\/10.2967\/jnumed.117.203109.","journal-title":"J Nucl Med"},{"key":"4810_CR45","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/01.WCB.0000038000.34930.4E","volume":"22","author":"M Ichise","year":"2002","unstructured":"Ichise M, Toyama H, Innis RB, Carson RE. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab. 2002;22:1271\u201381. https:\/\/doi.org\/10.1097\/01.WCB.0000038000.34930.4E.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4810_CR46","doi-asserted-by":"publisher","first-page":"e0177785","DOI":"10.1371\/journal.pone.0177785","volume":"12","author":"R Mabrouk","year":"2017","unstructured":"Mabrouk R, Strafella AP, Knezevic D, Ghadery C, Mizrahi R, Gharehgazlou A, et al. Feasibility study of TSPO quantification with [18F]FEPPA using population-based input function. PLoS One. 2017;12:e0177785. https:\/\/doi.org\/10.1371\/journal.pone.0177785.","journal-title":"PLoS One"},{"key":"4810_CR47","first-page":"2083","volume":"41","author":"M Slifstein","year":"2000","unstructured":"Slifstein M, Laruelle M. Effects of statistical noise on graphic analysis of PET neuroreceptor studies. J Nucl Med. 2000;41:2083\u20138.","journal-title":"J Nucl Med"},{"key":"4810_CR48","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s00259-006-0121-7","volume":"33","author":"PT Meyer","year":"2006","unstructured":"Meyer PT, Circiumaru V, Cardi CA, Thomas DH, Bal H, Acton PD. Simplified quantification of small animal [18F]FDG PET studies using a standard arterial input function. Eur J Nucl Med Mol Imaging. 2006;33:948\u201354. https:\/\/doi.org\/10.1007\/s00259-006-0121-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4810_CR49","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2967\/jnumed.114.146027","volume":"56","author":"CH Lyoo","year":"2015","unstructured":"Lyoo CH, Ikawa M, Liow JS, Zoghbi SS, Morse CL, Pike VW, et al. Cerebellum can serve as a pseudo-reference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein. J Nucl Med. 2015;56:701\u20136. https:\/\/doi.org\/10.2967\/jnumed.114.146027.","journal-title":"J Nucl Med"},{"key":"4810_CR50","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s11307-019-01323-8","volume":"21","author":"S Sridharan","year":"2019","unstructured":"Sridharan S, Raffel J, Nandoskar A, Record C, Brooks DJ, Owen D, et al. Confirmation of specific binding of the 18-kDa translocator protein (TSPO) radioligand [(18)F]GE-180: a blocking study using XBD173 in multiple sclerosis normal appearing white and grey matter. Mol Imaging Biol. 2019;21:935\u201344. https:\/\/doi.org\/10.1007\/s11307-019-01323-8.","journal-title":"Mol Imaging Biol"},{"key":"4810_CR51","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00259-018-4166-1","volume":"46","author":"M Unterrainer","year":"2019","unstructured":"Unterrainer M, Fleischmann DF, Diekmann C, Vomacka L, Lindner S, Vettermann F, et al. Comparison of (18)F-GE-180 and dynamic (18)F-FET PET in high grade glioma: a double-tracer pilot study. Eur J Nucl Med Mol Imaging. 2019;46:580\u201390. https:\/\/doi.org\/10.1007\/s00259-018-4166-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4810_CR52","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s00259-018-3974-7","volume":"45","author":"M Unterrainer","year":"2018","unstructured":"Unterrainer M, Mahler C, Vomacka L, Lindner S, Havla J, Brendel M, et al. TSPO PET with [(18)F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis. Eur J Nucl Med Mol Imaging. 2018;45:1423\u201331. https:\/\/doi.org\/10.1007\/s00259-018-3974-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4810_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13550-019-0486-9","volume":"9","author":"F Hofheinz","year":"2019","unstructured":"Hofheinz F, Maus J, Zschaeck S, Rogasch J, Schramm G, Oehme L, et al. Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET. EJNMMI Res. 2019;9:23. https:\/\/doi.org\/10.1186\/s13550-019-0486-9.","journal-title":"EJNMMI Res"},{"key":"4810_CR54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.dib.2018.04.133","volume":"19","author":"M Deussing","year":"2018","unstructured":"Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, et al. Data on specificity of [(18)F]GE180 uptake for TSPO expression in rodent brain and myocardium. Data Brief. 2018;19:331\u20136. https:\/\/doi.org\/10.1016\/j.dib.2018.04.133.","journal-title":"Data Brief"},{"key":"4810_CR55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuroimage.2017.10.006","volume":"165","author":"M Deussing","year":"2018","unstructured":"Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, et al. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [(18)F]GE180 PET quantification. Neuroimage. 2018;165:83\u201391. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.10.006.","journal-title":"Neuroimage."},{"key":"4810_CR56","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1007\/s00259-019-04294-8","volume":"46","author":"NL Albert","year":"2019","unstructured":"Albert NL, Unterrainer M, Brendel M, Kaiser L, Zweckstetter M, Cumming P, et al. In response to: the validity of (18)F-GE180 as a TSPO imaging agent. Eur J Nucl Med Mol Imaging. 2019;46:1208\u201311. https:\/\/doi.org\/10.1007\/s00259-019-04294-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4810_CR57","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00259-019-4268-4","volume":"46","author":"P Zanotti-Fregonara","year":"2019","unstructured":"Zanotti-Fregonara P, Veronese M, Pascual B, Rostomily RC, Turkheimer F, Masdeu JC. The validity of (18)F-GE180 as a TSPO imaging agent. Eur J Nucl Med Mol Imaging. 2019;46:1205\u20137. https:\/\/doi.org\/10.1007\/s00259-019-4268-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4810_CR58","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/0271678X17748786","volume":"38","author":"P Cumming","year":"2018","unstructured":"Cumming P, Burgher B, Patkar O, Breakspear M, Vasdev N, Thomas P, et al. Sifting through the surfeit of neuroinflammation tracers. J Cereb Blood Flow Metab. 2018;38:204\u201324. https:\/\/doi.org\/10.1177\/0271678X17748786.","journal-title":"J Cereb Blood Flow Metab"},{"key":"4810_CR59","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s00259-005-0052-8","volume":"33","author":"P Iversen","year":"2006","unstructured":"Iversen P, Hansen DA, Bender D, Rodell A, Munk OL, Cumming P, et al. Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy. Eur J Nucl Med Mol Imaging. 2006;33:810\u20136. https:\/\/doi.org\/10.1007\/s00259-005-0052-8.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04810-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-020-04810-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-04810-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T12:29:58Z","timestamp":1633609798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-020-04810-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4810"],"URL":"https:\/\/doi.org\/10.1007\/s00259-020-04810-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of the Hannover Medical School (reference no. 6525) and the Federal Office for Radiation Protection (reference no.: Z5 \u2013 22463\/2 \u2013 2015-030). All subjects had given written informed consent for participation in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}